AGP Executive Report
Last update: 12 hours agoDrug Regulation: China’s NMPA issued new compliance guidelines tightening oversight of online prescription-drug sales, aiming to curb misuse as e-commerce becomes a key route for branded and innovative medicines. Cancer Research: Antengene got CDE endorsement to start the pivotal Phase III CLINCH-3 study of ATG-022 (CLDN18.2 ADC) for CLDN18.2+ advanced gastric/GEJ cancer, with China-first multi-regional trial plans. Clinical Risk in Liver Disease: A study in HBV-related acute-on-chronic liver failure mapped distinct complication profiles, highlighting pneumonia, hepatic encephalopathy, and acute kidney injury as major severe events and pointing to factors like age and albumin levels for earlier risk stratification. Public Health Diplomacy: Nepal’s health minister met WHO chief Tedros, with WHO signaling readiness to cooperate and support Nepal; Bhutan also discussed strengthening health systems with India and China on the WHO Assembly sidelines. Wellness & Lifestyle: A review-style piece on black tea highlights fermented flavonoids and potential benefits tied to heart and cholesterol outcomes, while an anti-skin-aging plant extract study points to collagen and barrier protection mechanisms. Safety & Health Services: A blaze at a Midwood Chinese restaurant in New York sent three firefighters to hospital; hazmat teams removed lithium-ion batteries.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
